# Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency

Source: https://onco.cc/trials/nct06095141/  
OnCo record `nct06095141` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2/3 trial of cisplatin in pancreatic cancer, run by Fudan University, now recruiting.

## Summary

Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency is a phase 2/3, interventional study registered as NCT06095141 by Fudan University, with a registry enrolment figure of 30 participants, started 2023-12-01 and due to reach its primary completion in 2025-10-31. Interventions recorded: Cisplatin. Conditions listed: Pancreatic Adenocarcinoma; Homologous Recombination Deficiency. Primary outcome: progression-free survival, PFS. Pancreatic eligibility wording from the registry: "* Histologically or cytologically confirmed advanced pancreas adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: PTCA199-6
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06095141
- Phase: 2/3
- Setting: Cisplatin Based Regimen to Patients With Advanced Pancreatic Cancer and Homologous Recombination Deficiency
- Sponsor: Fudan University
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT06095141: https://clinicaltrials.gov/study/NCT06095141

## Connected records

- cancers: [BRCA or PALB2-mutant pancreatic ductal adenocarcinoma](https://onco.cc/cancers/brca-palb2-pdac/), [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Cisplatin](https://onco.cc/drugs/cisplatin/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06095141.json